SCHEMBL6024152

SCHEMBL6024152

CC(CCOC(=O)c1ccc(N)cc1)CCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.70
RAB9A P51151 4/20 0.70
ESR1 P03372 1/20 0.52
ESR2 Q92731 1/20 0.52
SCN1A P35498 2/20 0.51
SCN2A Q99250 2/20 0.51
SCN3A Q9NY46 2/20 0.51
CYP3A4 P08684 4/20 0.50
LMNA P02545 4/20 0.50
CYP1A2 P05177 3/20 0.50
TSHR P16473 3/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
PDE4D Q08499 1/20 0.50
PHLPP2 Q6ZVD8 1/20 0.49
ALDH1A1 P00352 2/20 0.48
MAPT P10636 1/20 0.48
MAOA P21397 2/20 0.48
CYP2D6 P10635 2/20 0.47
HTR3A P46098 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22283542 0.88 ESR1 (0.69) NPC1RAB9AESR1ESR2LMNA
SCHEMBL22283523 0.86 NPC1 (0.56) NPC1RAB9AESR1ESR2ALDH1A1
SCHEMBL453470 0.83 NPC1 (1.00) NPC1RAB9AESR1ESR2SCN1A
SCHEMBL223683 0.81 LMNA (0.65) NPC1RAB9AESR1ESR2LMNA
SCHEMBL31149440 0.80 SMN1; SMN2 (0.51) TSHRMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL4716884 0.80 SCN1A (0.58) NPC1RAB9ASCN1ASCN2ASCN3A
SCHEMBL15449675 0.80 SCN1A (0.58) NPC1RAB9ASCN1ASCN2ASCN3A
SCHEMBL27756504 0.80 SCN1A (0.58) NPC1RAB9ASCN1ASCN2ASCN3A
SCHEMBL6024231 0.80 SCN1A (0.58) NPC1RAB9ASCN1ASCN2ASCN3A
SCHEMBL6559718 0.79 ALDH1A1 (0.51) TSHRALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129204-B2 Perfumes QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-10-31 US claimed
EP-1286651-B1 USE OF AMINOBENZOIC ACIDS IN COMPOSITIONS WITH PERFUMES QUEST INT SERV BV (NL) 2006-08-02 EP claimed
US-20030199422-A1 Perfumes QUEST INTERNATIONAL SERVICES B.V. (NL) 2003-10-23 US claimed
EP-1286651-A1 IMPROVEMENTS IN OR RELATING TO PERFUMES QUEST INTERNATIONAL NEDERLAND BV (NL) 2003-03-05 EP claimed
WO-2001093823-A1 IMPROVEMENTS IN OR RELATING TO PERFUMES QUEST INTERNATIONAL B.V. (NL) 2001-12-13 WO claimed
US-7129204-B2 Perfumes QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-10-31 US disclosed
EP-1286651-B1 USE OF AMINOBENZOIC ACIDS IN COMPOSITIONS WITH PERFUMES QUEST INT SERV BV (NL) 2006-08-02 EP disclosed
US-20030199422-A1 Perfumes QUEST INTERNATIONAL SERVICES B.V. (NL) 2003-10-23 US disclosed
EP-1286651-A1 IMPROVEMENTS IN OR RELATING TO PERFUMES QUEST INTERNATIONAL NEDERLAND BV (NL) 2003-03-05 EP disclosed
WO-2001093823-A1 IMPROVEMENTS IN OR RELATING TO PERFUMES QUEST INTERNATIONAL B.V. (NL) 2001-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199422-A1 Perfumes PAH, PIR, TRPA1 NPC1 3760/4885RAB9A 4374/4885ESR1 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.